Cargando…
MG132 Induces Progerin Clearance and Improves Disease Phenotypes in HGPS-like Patients’ Cells
Progeroid syndromes (PS), including Hutchinson-Gilford Progeria Syndrome (HGPS), are premature and accelerated aging diseases, characterized by clinical features mimicking physiological aging. Most classical HGPS patients carry a de novo point mutation within exon 11 of the LMNA gene encoding A-type...
Autores principales: | Harhouri, Karim, Cau, Pierre, Casey, Frank, Guedenon, Koffi Mawuse, Doubaj, Yassamine, Van Maldergem, Lionel, Mejia-Baltodano, Gerardo, Bartoli, Catherine, De Sandre-Giovannoli, Annachiara, Lévy, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870437/ https://www.ncbi.nlm.nih.gov/pubmed/35203262 http://dx.doi.org/10.3390/cells11040610 |
Ejemplares similares
-
Antisense-Based Progerin Downregulation in HGPS-Like Patients’ Cells
por: Harhouri, Karim, et al.
Publicado: (2016) -
MG132‐induced progerin clearance is mediated by autophagy activation and splicing regulation
por: Harhouri, Karim, et al.
Publicado: (2017) -
New therapeutic approaches to HGPS based on progerin inhibition
por: Pellegrini, Camilla
Publicado: (2015) -
Progerin, an Aberrant Spliced Form of Lamin A, Is a Potential Therapeutic Target for HGPS
por: Kim, Bae-Hoon, et al.
Publicado: (2023) -
Presence and distribution of progerin in HGPS cells is ameliorated by drugs that impact on the mevalonate and mTOR pathways
por: Clements, Craig S., et al.
Publicado: (2019)